Vaccines

18 Jun 2007 Hypertension vaccine CYT006-AngQb achieves strong blood
14 Jun 2007 Novartis gains European approval for its innovative flu vaccine Optaflu(R)
14 Jun 2007 GlaxoSmithKline's application for DTaP-IPV vaccine is accepted for review by the FDA
12 Jun 2007 Opexa Presents Tovaxin(TM) Research at Federation of Clinical Immunology Societies Annual Meeting
12 Jun 2007 Orchestra Therapeutics announces new Phase II clinical data on NeuroVAX (TM) demonstrating marked expansion of regulatory T Cell populations in patients with multiple sclerosis
08 Jun 2007 Mymetics' HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
07 Jun 2007 All patients are enrolled in Curalogic’s clinical EU phase III trial with the ragweed product
06 Jun 2007 Encouraging clinical activity of GSK's novel cancer immunotherapeutic confirmed in phase II study in patients with most common form of lung cancer
06 Jun 2007 IDM Pharma Presents Preliminary Results from Phase II UVIDEM(R) Melanoma Vaccine Clinical Trial
06 Jun 2007 Coley Pharmaceutical Group's Vaccine Adjuvant, VaxImmune, to Enter Phase III Clinical Testing as Part of GlaxoSmithKline's Novel Cancer Immunotherapeutic in Non-Small Cell Lung Cancer
05 Jun 2007 IDM Pharma Presents Interim Phase II Data From EP-2101 Lung Cancer Vaccine Clinical Trial
05 Jun 2007 Introgen Announces Positive Phase 2 Clinical Trial Results with INGN 225 Immunotherapy in Patients with Small Cell Lung Cancer
02 Jun 2007 Transgene to Receive First Milestone Payment of EUR 10 Million From Roche Following FDA and EMEA Review of TG 4001 (R3484) Phase III Studies Plan
02 Jun 2007 Vakzine Projekt Management Reports Positive Clinical Trial Results With Their Therapeutic Prostate Cancer Vaccine VPM4001
01 Jun 2007 Vaxfectin(TM)-formulated Measles DNA Vaccine Elicits Long-term Protection and Sterilizing Immunity in Nonhuman Primates
01 Jun 2007 Dendreon Announces FDA Confirms Data Required for Provenge(R) Licensure
26 May 2007 Iomai Announces Interim Results From Phase 1 Study of Its Patch-Based Vaccine for Seasonal Influenza
26 May 2007 MedImmune Receives Correspondence From FDA Regarding FluMist(R)
25 May 2007 Cytos Biotechnology reports results from a phase I/IIa study
25 May 2007 Celldex Therapeutics Initiates a Definitive Phase 2/3 Clinical Trial of CDX- 110 in Patients with Glioblastoma Multiforme
24 May 2007 VGX Pharmaceuticals' Novel HIV and Pandemic Influenza DNA Vaccine Candidates Trigger Robust Immune Responses and Protection in Pre-Clinical Models
23 May 2007 Enzo Biochem Individualized Oral Immune Regulation Therapy
22 May 2007 Genitope Corporation Initiates Clinical Trial to Evaluate Use of MyVax(R) Personalized Immunotherapy Following Treatment With Rituximab and Chemotherapy for Follicular Non-Hodgkin's Lymphoma
19 May 2007 AVANT's Typhoid Fever Vaccine Demonstrates Excellent Clinical Potential
18 May 2007 Opexa Therapeutics Completes Patient Enrollment in Phase IIb Trial of Tovaxin(TM) for Treatment of Multiple Sclerosis

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top